Author + information
- Received June 17, 2010
- Revision received August 26, 2010
- Accepted September 7, 2010
- Published online November 1, 2010.
- ↵⁎Reprint requests and correspondence:
Dr. Farouc Jaffer, MGH Cardiovascular Research Center, 185 Cambridge Street, Simches Research Building 3206, Boston, Massachusetts 02114
Molecular imaging aims to enable personalized medicine via imaging-specific molecular and cellular targets that are relevant to the diagnosis and treatment of disease. By providing in vivo readouts of biological detail, molecular imaging complements traditional anatomical imaging modalities to allow: 1) visualization of important disease-modulating molecules and cells in vivo; 2) serial investigations to image evolutionary changes in disease attributes; and 3) evaluation of the in vivo molecular effects of biotherapeutics. The added information garnered by molecular imaging can improve risk assessment and prognosticative studies, this is of particular benefit in the management of cardiovascular disease (CVD).
This work was supported by a Howard Hughes Medical Institute Early Career Award, American Heart Association Scientist Development Grant#0830352N, and National Institutes of Health grant RO1 HL-108229. Dr. Jaffer was a prior consultant for VisEn Medical. Dr. Osborn reports that he has no relationships to disclose. The authors regret that additional excellent molecular imaging studies could not be included due to space limitations.
- Received June 17, 2010.
- Revision received August 26, 2010.
- Accepted September 7, 2010.
- American College of Cardiology Foundation